Ceterix Announces Results From Biomechanical Studies Of Minimally Invasive Orthopaedic Suturing Device

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif.--(BUSINESS WIRE)--Ceterix™ Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue procedures, today announced positive findings of recent biomechanical studies of the company’s proprietary NovoStitch™ technology.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC